200. Advancing a State of the Art Gene Therapy for Parkinson's Disease

Molecular Therapy - United States
doi 10.1016/s1525-0016(16)33805-9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

State-Of-The-Art 2003 on PKU Gene Therapy

Molecular Genetics and Metabolism
GeneticsMolecular BiologyBiochemistryEndocrinologyMetabolismDiabetes
2004English

Gene Therapy for Pediatric Cancer: State of the Art and Future Perspectives

Journal of Biomedicine and Biotechnology
2003English

Advancing State-Of-The-Art 3D Human Facial Recognition

SPIE Newsroom
2007English

A Phase I Study of Aromatic L-Amino Acid Decarboxylase Gene Therapy for Parkinson's Disease

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2010English

MRI-guided Phase 1 Trial of Putaminal AADC Gene Therapy for Parkinson's Disease

Annals of Neurology
Neurology
2019English

Metabotropic Glutamate Receptors for Parkinson's Disease Therapy

Parkinson's Disease
PsychiatryNeuroscienceMental HealthNeurology
2013English

The State of the Art of Adeno-Associated Virus-Based Vectors in Gene Therapy

Virology Journal
VirologyInfectious Diseases
2007English

Cardiac Resynchronization Therapy: State of the Art

Cardiac Electrophysiology Clinics
Cardiovascular MedicinePhysiologyCardiology
2015English

Opicapone: Once-Daily Adjunctive Therapy for Parkinson's Disease

Prescriber
Pharmacology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy